シンポジウム9：免疫介在性中枢神経疾患の病態と動物モデルを用いた治療法開発
自己抗体介在性神経障害性疼痛と免疫治療
2021 年 38 巻 4 号 p. 475-477
詳細
2021 年 38 巻 4 号 p. 475-477
Neuropathic pain often impairs quality of life in patients and becomes a global health issue. Recently, interaction between neuropathic pain and autoantibodies have been attracting much attention. Because autoantibody–mediated neuropathic pain is often a good response to immunotherapy, the detection of pain–generating autoantibodies may lead to clinical improvement in patients with intractable neuropathic pain.
In this review, we describe the clinical features of autoantibody–mediated neuropathic pain and novel candidate neuropathic pain–related autoantibodies.
